Webinar on the Societal & Ethical impact of Computational Modelling and simulation on New Treatment Development
Presented by EFGCP & Avicenna Alliance on the 25th of January 2018, 16.30 CET
Modern medicine development is not modern, it was simply the best we could do before the dawn of the digital age. Computational modelling and simulation has the potential to redesign healthcare delivery, conceptions of patient safety and the development and clinical trials of medicinal products and medical devices.
On the 25th of January, The European Forum for Good Clinical Practices (EFGCP) and Avicenna Alliance organise the first in a series of three webinars on Computational Modelling and Simulation. The webinars are moderated by Peter O'Donnell (Brussels Correspondent, APM Health Europe / European Columnist, Applied Clinical Trials). The first session will assess the societal and ethical impact of computational modelling and simulation on new treatment development. The focus of the event will lie on the impact related to gaps in regulation, compliance and ethics. The webinar begins at 16.30 PM CET and the panel includes several experts in the field.
I. Program of the first webinar:
This webinar will be moderated by Peter O'Donnell (Brussels Correspondent, APM Health Europe / European Columnist, Applied Clinical Trials) and will include presentations from:
- François-Henri Boissel, Novadiscovery (Avicenna Alliance)
- Ernst Singer, University of Vienna (Pharmacologist, former Chair Medical University of Vienna Ethics Committee)
- Nikos Dedes (EFGCP Board, former Co-Chair EMA Patients' and Consumers' Working Party)
II. Other webinars in this series:
Webinar 2: Practical Examples of CM&S in 21st Century Healthcare.
16:30 CET February 7. Moderated by Peter O'Donnell
Webinar 3: Modelling a Policy Framework for In Silico Medicine.
16:30 CET February 27 or 28. Moderated by Peter O'Donnell
Please register for the first webinar by clicking on the registration button displayed below. When the registration is successful, you will receive a confirmation email providing further information on joining the webinar.